What You Need to Know about the Link Between Gleevec and Heart Failure
Novartis adds congestive heart failure to Gleevec Precautions
October 3, 2006 (MedPage Today)
Novartis Oncology has announced that it is mailing information to U.S. doctors, informing them of a
possible link between Gleevec (imitinib mesylate) and congestive heart
failure.
Gleevec, an oral tyrosine kinase inhibitor approved by the
Food and Drug Administration in 2001, is prescribed for gastrointestinal stromal
tumors (GIST) and chronic myeloid leukemia.
Nature Medicine
published the results of animal studies that suggested that a side effect of
Gleevec may be cardiac dysfunction.
see also:
Xigris
FDA statement abut Xigris: drug can cause bleeding in sepsis patientsEarly communication issued by the FDA about Xigris safety review
Ziagen/Combivir
Tampering Led to Misbranding of Ziagen as Combivir, counterfeit labelsHIV Meds Ziagen & Combivir Mislabeled With Counterfeit Labels
Blood Glucose Meters
Abbott Notifies Users of Blood Glucose Meters to Check Display Screen Blood glucose test results could be compromised if meter is dropped
